Industrial Automation Magazine India

New Medical Device for Non-invasive, Whole-body Treatment

Published on : Tuesday 30-11--0001

AVACEN Medical announced partnering with Morulaa HealthTech of Chennai, India to introduce its AVACEN 100, Class II medical device, in India. Initial focus will be to reduce the number of limb amputations resulting from foot ulcers, a common complication associated with diabetes.

According to the Diabetic Foot Society in India, every year 200,000 diabetic patients in India undergo amputations of a leg for inadequately treated diabetic foot ulcers. This has a devastating impact on those who suffer from the amputation and their personal support systems. In addition, it imposes a large economic burden on public and private healthcare providers.

The AVACEN 100 uses an entirely new concept to increase microcirculation. It noninvasively and safely infuses heat into the circulatory system forcing the body to dilate peripheral capillaries to radiate off this excess heat. The company recently received CE (Conformité Européenne) Mark approval to market the AVACEN 100 to the European Union's 28 member countries to increase microcirculation during treatment.

"With over 1 million safe treatments, we frequently hear reports of rapid wound healing, especially after surgery. Recently our device was credited with saving the limb of a patient at a major university hospital who was given a 1 to 2% chance of retaining the limb by the attending physician. Closer to home, my diabetic mother would only have one leg if it wasn't for our device. That makes this product launch in India very personal," says AVACEN Medical CEO Thomas Muehlbauer. India has 70 million diabetics.

Health experts warn that India is on track to reach 120 million cases, or nearly 10 percent of the population, in the next eight years. That would put it on par with the United States, which counts 9.3 per cent of the population as diabetic, or China, where 11 per cent of the population – or 109 million – have been diagnosed, according to the International Diabetes Federation.

Contact:

AVACEN Medical
888-428-2236